C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study

scientific article published on 01 October 1994

C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID7894139

P2093author name stringNakopoulou L
Stefanaki K
Giannopoulou I
Filaktopoulos D
P433issue4
P921main subjectimmunohistochemistryQ899285
hepatocellular carcinomaQ1148337
P304page(s)677-682
P577publication date1994-10-01
P1433published inHistology & HistopathologyQ13726949
P1476titleC-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study
P478volume9

Reverse relations

cites work (P2860)
Q34611637A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas
Q36622264Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma
Q28078111HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
Q41902323Immunohistochemical study on p53, H-rasp21, c-erbB-2 protein and PCNA expression in HCC tissues of Han and minority ethnic patients
Q35588545Overexpression/amplification of HER-2/neu is uncommon in hepatocellular carcinoma
Q64279990Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Q36708741Sorafenib: where do we go from here?
Q42180761TOP2A amplification and overexpression in hepatocellular carcinoma tissues.
Q35207561Targeted therapy in hepatocellular carcinoma
Q36395424The Predictive and Prognostic Significance of c-erb-B2, EGFR, PTEN, mTOR, PI3K, p27, and ERCC1 Expression in Hepatocellular Carcinoma

Search more.